These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 28732748

  • 21. Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study.
    van de Kerkhof PCM, Loewe R, Mrowietz U, Falques M, Pau-Charles I, Szepietowski JC.
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):119-126. PubMed ID: 31465585
    [Abstract] [Full Text] [Related]

  • 22. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network.
    Ockenfels HM, Schultewolter T, Ockenfels G, Funk R, Goos M.
    Br J Dermatol; 1998 Sep; 139(3):390-5. PubMed ID: 9767281
    [Abstract] [Full Text] [Related]

  • 23. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
    Wang Y, Zhao J, Zhang L, Di T, Liu X, Lin Y, Zeng Z, Li P.
    Int J Clin Exp Pathol; 2015 Sep; 8(6):6665-73. PubMed ID: 26261548
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
    Thomas K, Dietze K, Wehner R, Metz I, Tumani H, Schultheiß T, Günther C, Schäkel K, Reichmann H, Brück W, Schmitz M, Ziemssen T.
    Neurol Neuroimmunol Neuroinflamm; 2014 Oct; 1(3):e33. PubMed ID: 25340085
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. FcγRIII (CD16) equips immature 6-sulfo LacNAc-expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens.
    Döbel T, Kunze A, Babatz J, Tränkner K, Ludwig A, Schmitz M, Enk A, Schäkel K.
    Blood; 2013 May 02; 121(18):3609-18. PubMed ID: 23460612
    [Abstract] [Full Text] [Related]

  • 28. Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.
    Mager K, Wehner R, Bahr F, Oelschlägel U, Platzbecker U, Wermke M, Shayegi N, Middeke JM, Radke J, Röllig C, Schetelig J, Thiede C, Ehninger G, Schmitz M, Bornhäuser M, Tuve S.
    Transplantation; 2012 Jun 27; 93(12):1270-5. PubMed ID: 22643330
    [Abstract] [Full Text] [Related]

  • 29. Increased Numbers of 6-sulfo LacNAc (slan) Dendritic Cells in Hand Transplant Recipients.
    Baran W, Koziol M, Woźniak Z, Banasik M, Boratyńska M, Kunze A, Schakel K.
    Ann Transplant; 2015 Oct 29; 20():649-54. PubMed ID: 26510404
    [Abstract] [Full Text] [Related]

  • 30. Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis.
    Traub J, Traffehn S, Ochs J, Häusser-Kinzel S, Stephan S, Scannevin R, Brück W, Metz I, Weber MS.
    Brain Pathol; 2019 Sep 29; 29(5):640-657. PubMed ID: 30706542
    [Abstract] [Full Text] [Related]

  • 31. Effects of monomethylfumarate on dendritic cell differentiation.
    Litjens NH, Rademaker M, Ravensbergen B, Thio HB, van Dissel JT, Nibbering PH.
    Br J Dermatol; 2006 Feb 29; 154(2):211-7. PubMed ID: 16433787
    [Abstract] [Full Text] [Related]

  • 32. Dendritic cells: The driver of psoriasis.
    Wang A, Bai Y.
    J Dermatol; 2020 Feb 29; 47(2):104-113. PubMed ID: 31833093
    [Abstract] [Full Text] [Related]

  • 33. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P, Norsgaard H, Tokura Y, Røpke MA.
    J Dermatol Sci; 2016 Mar 29; 81(3):153-64. PubMed ID: 26794805
    [Abstract] [Full Text] [Related]

  • 34. Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis.
    Wada Y, Cardinale I, Khatcherian A, Chu J, Kantor AB, Gottlieb AB, Tatsuta N, Jacobson E, Barsoum J, Krueger JG.
    PLoS One; 2012 Mar 29; 7(4):e35069. PubMed ID: 22493730
    [Abstract] [Full Text] [Related]

  • 35. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells.
    Ghoreschi K, Brück J, Kellerer C, Deng C, Peng H, Rothfuss O, Hussain RZ, Gocke AR, Respa A, Glocova I, Valtcheva N, Alexander E, Feil S, Feil R, Schulze-Osthoff K, Rupec RA, Lovett-Racke AE, Dringen R, Racke MK, Röcken M.
    J Exp Med; 2011 Oct 24; 208(11):2291-303. PubMed ID: 21987655
    [Abstract] [Full Text] [Related]

  • 36. Histamine H(4) receptor activation on human slan-dendritic cells down-regulates their pro-inflammatory capacity.
    Gschwandtner M, Schäkel K, Werfel T, Gutzmer R.
    Immunology; 2011 Jan 24; 132(1):49-56. PubMed ID: 20722760
    [Abstract] [Full Text] [Related]

  • 37. TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.
    Frischer JM, Reindl M, Künz B, Berger T, Schmidt S, Milford EL, Knosp E, Lassmann H, Utku N.
    Mult Scler; 2014 Aug 24; 20(9):1171-81. PubMed ID: 24526664
    [Abstract] [Full Text] [Related]

  • 38. T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets.
    Alonso MN, Wong MT, Zhang AL, Winer D, Suhoski MM, Tolentino LL, Gaitan J, Davidson MG, Kung TH, Galel DM, Nadeau KC, Kim J, Utz PJ, Söderström K, Engleman EG.
    Blood; 2011 Sep 22; 118(12):3311-20. PubMed ID: 21813450
    [Abstract] [Full Text] [Related]

  • 39. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.
    Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ.
    J Immunol; 1995 Mar 15; 154(6):2668-77. PubMed ID: 7533180
    [Abstract] [Full Text] [Related]

  • 40. Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous T helper 1 and 17 inflammatory pathways.
    Reich K, Reich JLK, Falk TM, Blödorn-Schlicht N, Mrowietz U, von Kiedrowski R, Pfeiffer C, Niesmann J, Frambach Y, Warren RB.
    Br J Dermatol; 2019 Oct 15; 181(4):859-862. PubMed ID: 30972731
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.